DIEN DO: Open Payments
NPI 1609326289 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 32 payments from 8 companies in 2025. Trend: 2023 $182 · 2024 $372 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $261 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $171 |
| Collegium Pharmaceutical, Inc. | 5 | $90 |
| Medtronic, Inc. | 2 | $71 |
| Valinor Pharma, LLC | 3 | $58 |
| Globus Medical, Inc. | 2 | $38 |
| Boston Scientific Corporation | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
Products named: PROCLAIM, RELISTOR, XTAMPZA, OCTRODE, MOVANTIK, Senza, SPECIFY SURESCAN MRI 5-6-5, KYPHON EXPRESS II KYPHOPAK TRAY.
Industry payments across AZ — which companies pay providers there.
